The present invention relates to a composition for preventing and treating cancer-related fatigue, characterized by containing a new processed ginseng powder or a new processed ginseng extract having an increased amount of a ginsenoside constituent, which was previously minute, by preparing a saponin-decomposing enzyme and subsequently using hydrolysis by the prepared saponin-decomposing enzyme and an organic acid. The composition according to the present invention can be very effectively used for preventing and treating cancer-related fatigue, the most destructive and universal side effect, which is caused by cancer itself or occurs in association with the treatment of cancer.

A composition is provided. The composition contains: (A) a psychoactive compound selected from the group consisting of psilocybin, psilocin, and combinations thereof; and (B) a supplement selected from the group consisting of an amino acid, a vitamin B6, piracetam, gamma aminobutyric acid (GABA), theobromine, caffeine, resveratrol, and combinations thereof. A method of producing the composition and an oral dosage containing the composition are also provided.

A composition is provided. The composition contains: (A) a psychoactive compound selected from the group consisting of psilocybin, psilocin, and combinations thereof; and (B) a supplement selected from the group consisting of an amino acid, a vitamin B6, piracetam, gamma aminobutyric acid (GABA), theobromine, caffeine, resveratrol, and combinations thereof. A method of producing the composition and an oral dosage containing the composition are also provided.

Provided is a composition, including: an aqueous suspension, comprising: a first plurality of active ingredients, and one or more nanoparticles, wherein: the one or more nanoparticles encapsulate a second plurality of active ingredients; the second plurality of active ingredients are insoluble in the aqueous suspension; the one or more nanoparticles solubilize the second plurality of active ingredients in the aqueous suspension; and the one or more nanoparticles have a Z-average diameter between 50 to 950 nanometers.

Provided is a composition, including: an aqueous suspension, comprising: a first plurality of active ingredients, and one or more nanoparticles, wherein: the one or more nanoparticles encapsulate a second plurality of active ingredients; the second plurality of active ingredients are insoluble in the aqueous suspension; the one or more nanoparticles solubilize the second plurality of active ingredients in the aqueous suspension; and the one or more nanoparticles have a Z-average diameter between 50 to 950 nanometers.

A composition for preventing and treating heart dysfunction and its application thereof, including approximately 6-10% coenzyme Q10, approximately 40-45% Radix salviae Militiorrhizae and approximately 40-45% Radix notoginseng, which is prepared into an oral application such as tablets, capsules, granules or powders in sachets, pills, and oral solution. The extract of Radix salviae Militiorrhizae is a water-soluble extract of the root of Salvia miltiorrhiza Bunge and the powder of Radix notoginseng is a fine powder of the root of Panax notoginseng (Burk.). The composition can be prepared into a dietary supplement for improving heart function or a medicament for treating heart dysfunction by preventing heart failure, treating myocardial injury caused by hypoxia or reperfusion, treating abnormal heartbeat, treating palpitation, relieving pericardial edema, or treating palpitation and chest tightness caused by dysautonomia.

A composition for preventing and treating heart dysfunction and its application thereof, including approximately 6-10% coenzyme Q10, approximately 40-45% Radix salviae Militiorrhizae and approximately 40-45% Radix notoginseng, which is prepared into an oral application such as tablets, capsules, granules or powders in sachets, pills, and oral solution. The extract of Radix salviae Militiorrhizae is a water-soluble extract of the root of Salvia miltiorrhiza Bunge and the powder of Radix notoginseng is a fine powder of the root of Panax notoginseng (Burk.). The composition can be prepared into a dietary supplement for improving heart function or a medicament for treating heart dysfunction by preventing heart failure, treating myocardial injury caused by hypoxia or reperfusion, treating abnormal heartbeat, treating palpitation, relieving pericardial edema, or treating palpitation and chest tightness caused by dysautonomia.

A composition for preventing and treating heart dysfunction and its application thereof, including approximately 6-10% coenzyme Q10, approximately 40-45% Radix salviae Militiorrhizae and approximately 40-45% Radix notoginseng, which is prepared into an oral application such as tablets, capsules, granules or powders in sachets, pills, and oral solution. The extract of Radix salviae Militiorrhizae is a water-soluble extract of the root of Salvia miltiorrhiza Bunge and the powder of Radix notoginseng is a fine powder of the root of Panax notoginseng (Burk.). The composition can be prepared into a dietary supplement for improving heart function or a medicament for treating heart dysfunction by preventing heart failure, treating myocardial injury caused by hypoxia or reperfusion, treating abnormal heartbeat, treating palpitation, relieving pericardial edema, or treating palpitation and chest tightness caused by dysautonomia.

Described herein are compositions for reducing body weight, reducing body fat, improving body composition and/or preventing obesity and related conditions. In certain aspects, the compositions comprise dileucine, and a pharmaceutically acceptable carrier thereof. In certain embodiments, the composition comprises dileucine and leucine. In further aspects, the dileucine is present from about 10% to 90% (w/w). In further aspects, the dileucine is present from about 20% to 80% (w/w). In further aspects, wherein the dileucine is present from about 30% to 70% (w/w). In further aspects, the dileucine is present from about 40% to 60% (w/w).

Described herein are compositions for reducing body weight, reducing body fat, improving body composition and/or preventing obesity and related conditions. In certain aspects, the compositions comprise dileucine, and a pharmaceutically acceptable carrier thereof. In certain embodiments, the composition comprises dileucine and leucine. In further aspects, the dileucine is present from about 10% to 90% (w/w). In further aspects, the dileucine is present from about 20% to 80% (w/w). In further aspects, wherein the dileucine is present from about 30% to 70% (w/w). In further aspects, the dileucine is present from about 40% to 60% (w/w).